...
首页> 外文期刊>Oncology letters >Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions
【24h】

Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions

机译:高,低地方性传染病地区ABC弥漫性大B细胞淋巴瘤患者淋巴瘤组织中病毒制剂的差异表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation and the integration of oncogenes, and have previously been indicated in cervical cancer, hepatocellular carcinoma, gastric cancer and lymphoproliferative disorders. In the present study, the presence of microbial agents was analyzed in the lymphoma tissue of patients with activated B-cell like (ABC) DLBCL. The present study compared two groups of patients from geographically varied regions that possess a difference in the prevalence of viral and other microbial agents. The patient populations were from Sweden (a low endemic infectious disease region) and Egypt (a high endemic infectious disease region). A differential expression of several viruses in lymphoma tissues was noted when comparing Swedish and Egyptian patients. JC polyomavirus (JCV) was detected in Swedish and Egyptian patients and, uniquely, the complete hepatitis B virus (HBV) genome was detected only in Egyptian lymphoma patients. None of these viruses were detected in control lymph tissues from Sweden or Egypt. In total, 38% of the Egyptian patients were found to have HBV surface antigens (HBsAgs) in their serum; however, HBsAgs were not found in any of the Swedish patients. The percentage of serum HBsAgs in Egyptian patients with ABC DLBCL was significantly increased compared with the general Egyptian population (P<0.05). The present study may support a notion that viral agents, including JCV and HBV, may be involved in the tumorigenesis of DLBCL in regions of high infectious disease.
机译:弥漫性大B细胞淋巴瘤(DLBCL)是成人中最常见的非霍奇金淋巴瘤(NHL)类型,约占全球新诊断淋巴瘤的30-40%。环境因素,例如病毒和细菌,可能通过慢性炎症和癌基因的整合而促进癌症的发展,并且先前已在宫颈癌,肝细胞癌,胃癌和淋巴增生性疾病中得到了应用。在本研究中,分析了活化B细胞样(ABC)DLBCL患者的淋巴瘤组织中微生物制剂的存在。本研究比较了来自不同地理区域的两组患者,这些患者在病毒和其他微生物制剂的流行方面存在差异。患者人群来自瑞典(低流行性传染病地区)和埃及(高流行性传染病地区)。比较瑞典和埃及患者时,注意到几种病毒在淋巴瘤组织中的差异表达。在瑞典和埃及患者中检测到JC多瘤病毒(JCV),唯一的是,仅在埃及淋巴瘤患者中检测到完整的乙肝病毒(HBV)基因组。在瑞典或埃及的对照淋巴组织中未检测到这些病毒。总共有38%的埃及患者的血清中存在HBV表面抗原(HBsAgs)。但是,在任何瑞典患者中均未发现HBsAg。与埃及普通人群相比,埃及ABC DLBCL患者的血清HBsAgs百分比显着增加(P <0.05)。本研究可能支持一种观念,即包括JCV和HBV在内的病毒制剂可能参与了高传染性疾病地区DLBCL的肿瘤发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号